C R Blagg, B H Scribner. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Cost-Benefit AnalysisHumansKidney Failure, Chronic/mortalityKidney Failure, Chronic/therapyMedicare/economicsUnited States
Year: 1980 PMID: 6776860 DOI: 10.7326/0003-4819-93-3-501
Source DB: PubMed Journal: Ann Intern Med ISSN: 0003-4819 Impact factor: 25.391